The global Human Chorionic Gonadotropin (HCG) market size is expected to reach US$ 1173.2 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029.

Human Chorionic Gonadotropin (HCG) - Market

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

The market is mainly driven by the significant applications of Human Chorionic Gonadotropin (HCG) in various end use industries. The expanding demands from the Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment and Others, are propelling Human Chorionic Gonadotropin (HCG) market. Natural Source Extraction, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant DNA Technology segment is estimated at % CAGR for the next seven-year period.

The growth of the human chorionic gonadotropin (HCG) market is attributed to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment. Hypogonadism, for example, is characterized by low serum testosterone concentration, which is followed by a number of clinical features such as erectile dysfunction (ED), poor morning erections, low libido, memory loss, physical decline in strength and health, difficulty concentrating, and depression.According to the study published by BMC Endocrine Disorders in July 2021, erectile dysfunction was found to be prevalent in 72.2% of people globally in 2021. Furthermore, according to the CDC update in March 2022, about 1 in 5 (22%) couples in which the woman is 30-39 have problems conceiving their first child, compared to about 1 in 8 (13%) couples in which the woman is younger than 30. Age-related fertility loss is mostly caused by deteriorating egg quality. Older women also have fewer remaining eggs and are more likely to have health issues that can affect fertility. Aging also increases a woman’s chances of miscarriage and of having a child with a genetic abnormality. Therefore, the high burden of infertility is also raising the demand for effective treatments such as human chorionic gonadotropin (HCG) hormones, which is fueling the market's growth.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Chorionic Gonadotropin (HCG), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Human Chorionic Gonadotropin (HCG) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Human Chorionic Gonadotropin (HCG) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Chorionic Gonadotropin (HCG) sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Human Chorionic Gonadotropin (HCG) covered in this report include EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, Scripps Laboratories, Leebio, Kamiya Biomedical Company and Sanzyme, etc.

The global Human Chorionic Gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

EMD Serono, Inc

Ferring B.V

Merck & Co., Inc

Bristol Myers Squibb Company

Fresenius Kabi AG

Scripps Laboratories

Leebio

Kamiya Biomedical Company

Sanzyme

Cigna

LUPIN

Sun Pharmaceutical Industries Ltd

Serum Institute of India Pvt. Ltd

VHB Medi Sciences Limited

Zydus Lifesciences Ltd

Corona Remedies Pvt. Ltd.

Scope of Human Chorionic Gonadotropin (HCG) - Market Report

Report Metric	Details
Report Name	Human Chorionic Gonadotropin (HCG) - Market
Forecasted market size in 2029	US$ 1173.2 million
CAGR	6.6%
Forecasted years	2023 - 2029
Global Human Chorionic Gonadotropin (HCG) market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Chorionic Gonadotropin (HCG) market, Segment by Type:	Natural Source Extraction Recombinant DNA Technology
Global Human Chorionic Gonadotropin (HCG) market, by Application	Female Infertility Treatment Oligospermic Treatment Cryptorchidism Treatment Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Chorionic Gonadotropin (HCG) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Human Chorionic Gonadotropin (HCG) - Market size in 2029?

Ans: The Human Chorionic Gonadotropin (HCG) - Market size in 2029 will be US$ 1173.2 million.

What are the Application segmentation covered in the Human Chorionic Gonadotropin (HCG) - Market report?

Ans: The Applications covered in the Human Chorionic Gonadotropin (HCG) - Market report are Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Others

What are the Type segmentation covered in the Human Chorionic Gonadotropin (HCG) - Market report?

Ans: The Types covered in the Human Chorionic Gonadotropin (HCG) - Market report are Natural Source Extraction, Recombinant DNA Technology

1 Market Overview of Human Chorionic Gonadotropin (HCG)

1.1 Human Chorionic Gonadotropin (HCG) Market Overview

1.1.1 Human Chorionic Gonadotropin (HCG) Product Scope

1.1.2 Human Chorionic Gonadotropin (HCG) Market Status and Outlook

1.2 Global Human Chorionic Gonadotropin (HCG) Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2018-2029)

1.4 Global Human Chorionic Gonadotropin (HCG) Historic Market Size by Region (2018-2023)

1.5 Global Human Chorionic Gonadotropin (HCG) Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Human Chorionic Gonadotropin (HCG) Market Size (2018-2029)

1.6.1 North America Human Chorionic Gonadotropin (HCG) Market Size (2018-2029)

1.6.2 Europe Human Chorionic Gonadotropin (HCG) Market Size (2018-2029)

1.6.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size (2018-2029)

1.6.4 Latin America Human Chorionic Gonadotropin (HCG) Market Size (2018-2029)

1.6.5 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size (2018-2029)

2 Human Chorionic Gonadotropin (HCG) Market by Type

2.1 Introduction

2.1.1 Natural Source Extraction

2.1.2 Recombinant DNA Technology

2.2 Global Human Chorionic Gonadotropin (HCG) Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Human Chorionic Gonadotropin (HCG) Historic Market Size by Type (2018-2023)

2.2.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Type (2018-2029)

3 Human Chorionic Gonadotropin (HCG) Market Overview by Application

3.1 Introduction

3.1.1 Female Infertility Treatment

3.1.2 Oligospermic Treatment

3.1.3 Cryptorchidism Treatment

3.1.4 Others

3.2 Global Human Chorionic Gonadotropin (HCG) Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Human Chorionic Gonadotropin (HCG) Historic Market Size by Application (2018-2023)

3.2.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Breakdown by Application (2018-2029)

4 Human Chorionic Gonadotropin (HCG) Competition Analysis by Players

4.1 Global Human Chorionic Gonadotropin (HCG) Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2022)

4.3 Date of Key Players Enter into Human Chorionic Gonadotropin (HCG) Market

4.4 Global Top Players Human Chorionic Gonadotropin (HCG) Headquarters and Area Served

4.5 Key Players Human Chorionic Gonadotropin (HCG) Product Solution and Service

4.6 Competitive Status

4.6.1 Human Chorionic Gonadotropin (HCG) Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 EMD Serono, Inc

5.1.1 EMD Serono, Inc Profile

5.1.2 EMD Serono, Inc Main Business

5.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.1.5 EMD Serono, Inc Recent Developments

5.2 Ferring B.V

5.2.1 Ferring B.V Profile

5.2.2 Ferring B.V Main Business

5.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.2.5 Ferring B.V Recent Developments

5.3 Merck & Co., Inc

5.3.1 Merck & Co., Inc Profile

5.3.2 Merck & Co., Inc Main Business

5.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.3.5 Bristol Myers Squibb Company Recent Developments

5.4 Bristol Myers Squibb Company

5.4.1 Bristol Myers Squibb Company Profile

5.4.2 Bristol Myers Squibb Company Main Business

5.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.4.5 Bristol Myers Squibb Company Recent Developments

5.5 Fresenius Kabi AG

5.5.1 Fresenius Kabi AG Profile

5.5.2 Fresenius Kabi AG Main Business

5.5.3 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.5.4 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.5.5 Fresenius Kabi AG Recent Developments

5.6 Scripps Laboratories

5.6.1 Scripps Laboratories Profile

5.6.2 Scripps Laboratories Main Business

5.6.3 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.6.4 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.6.5 Scripps Laboratories Recent Developments

5.7 Leebio

5.7.1 Leebio Profile

5.7.2 Leebio Main Business

5.7.3 Leebio Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.7.4 Leebio Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.7.5 Leebio Recent Developments

5.8 Kamiya Biomedical Company

5.8.1 Kamiya Biomedical Company Profile

5.8.2 Kamiya Biomedical Company Main Business

5.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.8.5 Kamiya Biomedical Company Recent Developments

5.9 Sanzyme

5.9.1 Sanzyme Profile

5.9.2 Sanzyme Main Business

5.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.9.5 Sanzyme Recent Developments

5.10 Cigna

5.10.1 Cigna Profile

5.10.2 Cigna Main Business

5.10.3 Cigna Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.10.4 Cigna Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.10.5 Cigna Recent Developments

5.11 LUPIN

5.11.1 LUPIN Profile

5.11.2 LUPIN Main Business

5.11.3 LUPIN Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.11.4 LUPIN Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.11.5 LUPIN Recent Developments

5.12 Sun Pharmaceutical Industries Ltd

5.12.1 Sun Pharmaceutical Industries Ltd Profile

5.12.2 Sun Pharmaceutical Industries Ltd Main Business

5.12.3 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.12.4 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.12.5 Sun Pharmaceutical Industries Ltd Recent Developments

5.13 Serum Institute of India Pvt. Ltd

5.13.1 Serum Institute of India Pvt. Ltd Profile

5.13.2 Serum Institute of India Pvt. Ltd Main Business

5.13.3 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.13.4 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.13.5 Serum Institute of India Pvt. Ltd Recent Developments

5.14 VHB Medi Sciences Limited

5.14.1 VHB Medi Sciences Limited Profile

5.14.2 VHB Medi Sciences Limited Main Business

5.14.3 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.14.4 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.14.5 VHB Medi Sciences Limited Recent Developments

5.15 Zydus Lifesciences Ltd

5.15.1 Zydus Lifesciences Ltd Profile

5.15.2 Zydus Lifesciences Ltd Main Business

5.15.3 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.15.4 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.15.5 Zydus Lifesciences Ltd Recent Developments

5.16 Corona Remedies Pvt. Ltd.

5.16.1 Corona Remedies Pvt. Ltd. Profile

5.16.2 Corona Remedies Pvt. Ltd. Main Business

5.16.3 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

5.16.4 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2018-2023)

5.16.5 Corona Remedies Pvt. Ltd. Recent Developments

6 North America

6.1 North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Human Chorionic Gonadotropin (HCG) Market Dynamics

11.1 Human Chorionic Gonadotropin (HCG) Industry Trends

11.2 Human Chorionic Gonadotropin (HCG) Market Drivers

11.3 Human Chorionic Gonadotropin (HCG) Market Challenges

11.4 Human Chorionic Gonadotropin (HCG) Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

EMD Serono Inc

Ferring B.V.

Merck& Co. Inc

Bristol Myers Squibb Company

Leebio

Kamiya Biomedical Company

Sun Pharmaceutical Industries Ltd.

Serum Institute of India Pvt. Ltd

Zydus Lifesciences Ltd

Corona Remedies Pvt Ltd

VHB Medi Sciences Limited

List of Tables

Table 1. Global Market Human Chorionic Gonadotropin (HCG) Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Human Chorionic Gonadotropin (HCG) Market Size Share by Region (2018-2023)

Table 4. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Human Chorionic Gonadotropin (HCG) Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Human Chorionic Gonadotropin (HCG) Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2023)

Table 9. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2024-2029)

Table 11. North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Human Chorionic Gonadotropin (HCG) Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Human Chorionic Gonadotropin (HCG) Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2023)

Table 24. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2024-2029)

Table 26. North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2022)

Table 39. Date of Key Players Enter into Human Chorionic Gonadotropin (HCG) Market

Table 40. Global Human Chorionic Gonadotropin (HCG) Key Players Headquarters and Area Served

Table 41. Human Chorionic Gonadotropin (HCG) Product Solution and Service

Table 42. Global Human Chorionic Gonadotropin (HCG) Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. EMD Serono, Inc Basic Information List

Table 45. EMD Serono, Inc Description and Business Overview

Table 46. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 47. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of EMD Serono, Inc (2018-2023)

Table 48. EMD Serono, Inc Recent Developments

Table 49. Ferring B.V Basic Information List

Table 50. Ferring B.V Description and Business Overview

Table 51. Ferring B.V Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 52. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Ferring B.V (2018-2023)

Table 53. Ferring B.V Recent Developments

Table 54. Merck & Co., Inc Basic Information List

Table 55. Merck & Co., Inc Description and Business Overview

Table 56. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 57. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Merck & Co., Inc (2018-2023)

Table 58. Merck & Co., Inc Recent Developments

Table 59. Bristol Myers Squibb Company Basic Information List

Table 60. Bristol Myers Squibb Company Description and Business Overview

Table 61. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 62. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Bristol Myers Squibb Company (2018-2023)

Table 63. Bristol Myers Squibb Company Recent Developments

Table 64. Fresenius Kabi AG Basic Information List

Table 65. Fresenius Kabi AG Description and Business Overview

Table 66. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 67. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Fresenius Kabi AG (2018-2023)

Table 68. Fresenius Kabi AG Recent Developments

Table 69. Scripps Laboratories Basic Information List

Table 70. Scripps Laboratories Description and Business Overview

Table 71. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 72. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Scripps Laboratories (2018-2023)

Table 73. Scripps Laboratories Recent Developments

Table 74. Leebio Basic Information List

Table 75. Leebio Description and Business Overview

Table 76. Leebio Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 77. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Leebio (2018-2023)

Table 78. Leebio Recent Developments

Table 79. Kamiya Biomedical Company Basic Information List

Table 80. Kamiya Biomedical Company Description and Business Overview

Table 81. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 82. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Kamiya Biomedical Company (2018-2023)

Table 83. Kamiya Biomedical Company Recent Developments

Table 84. Sanzyme Basic Information List

Table 85. Sanzyme Description and Business Overview

Table 86. Sanzyme Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 87. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Sanzyme (2018-2023)

Table 88. Sanzyme Recent Developments

Table 89. Cigna Basic Information List

Table 90. Cigna Description and Business Overview

Table 91. Cigna Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 92. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Cigna (2018-2023)

Table 93. Cigna Recent Developments

Table 94. LUPIN Basic Information List

Table 95. LUPIN Description and Business Overview

Table 96. LUPIN Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 97. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of LUPIN (2018-2023)

Table 98. LUPIN Recent Developments

Table 99. Sun Pharmaceutical Industries Ltd Basic Information List

Table 100. Sun Pharmaceutical Industries Ltd Description and Business Overview

Table 101. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 102. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Sun Pharmaceutical Industries Ltd (2018-2023)

Table 103. Sun Pharmaceutical Industries Ltd Recent Developments

Table 104. Serum Institute of India Pvt. Ltd Basic Information List

Table 105. Serum Institute of India Pvt. Ltd Description and Business Overview

Table 106. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 107. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Serum Institute of India Pvt. Ltd (2018-2023)

Table 108. Serum Institute of India Pvt. Ltd Recent Developments

Table 109. VHB Medi Sciences Limited Basic Information List

Table 110. VHB Medi Sciences Limited Description and Business Overview

Table 111. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 112. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of VHB Medi Sciences Limited (2018-2023)

Table 113. VHB Medi Sciences Limited Recent Developments

Table 114. Zydus Lifesciences Ltd Basic Information List

Table 115. Zydus Lifesciences Ltd Description and Business Overview

Table 116. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 117. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Zydus Lifesciences Ltd (2018-2023)

Table 118. Zydus Lifesciences Ltd Recent Developments

Table 119. Corona Remedies Pvt. Ltd. Basic Information List

Table 120. Corona Remedies Pvt. Ltd. Description and Business Overview

Table 121. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Products, Services and Solutions

Table 122. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Corona Remedies Pvt. Ltd. (2018-2023)

Table 123. Corona Remedies Pvt. Ltd. Recent Developments

Table 124. North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2023) & (US$ Million)

Table 125. North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2024-2029) & (US$ Million)

Table 126. Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2023) & (US$ Million)

Table 127. Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2024-2029) & (US$ Million)

Table 128. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 129. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region (2018-2023) & (US$ Million)

Table 130. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region (2024-2029) & (US$ Million)

Table 131. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share by Region (2018-2023)

Table 132. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share by Region (2024-2029)

Table 133. Latin America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 134. Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2023) & (US$ Million)

Table 135. Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2024-2029) & (US$ Million)

Table 136. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 137. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2018-2023) & (US$ Million)

Table 138. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2024-2029) & (US$ Million)

Table 139. Human Chorionic Gonadotropin (HCG) Market Trends

Table 140. Human Chorionic Gonadotropin (HCG) Market Drivers

Table 141. Human Chorionic Gonadotropin (HCG) Market Challenges

Table 142. Human Chorionic Gonadotropin (HCG) Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Human Chorionic Gonadotropin (HCG) Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Human Chorionic Gonadotropin (HCG) Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Human Chorionic Gonadotropin (HCG) Market Share by Regions: 2022 VS 2029

Figure 4. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Natural Source Extraction

Figure 11. Global Natural Source Extraction Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Recombinant DNA Technology

Figure 13. Global Recombinant DNA Technology Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Global Human Chorionic Gonadotropin (HCG) Market Size Share by Type: 2022 & 2029

Figure 15. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2029)

Figure 16. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2029)

Figure 17. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2029)

Figure 18. Latin America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2029)

Figure 19. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2029)

Figure 20. Female Infertility Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 21. Oligospermic Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Cryptorchidism Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 24. Global Human Chorionic Gonadotropin (HCG) Market Size Share by Application: 2022 & 2029

Figure 25. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2029)

Figure 26. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2029)

Figure 27. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2029)

Figure 28. Latin America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2029)

Figure 29. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2029)

Figure 30. Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 31. Global Top 5 and Top 10 Players Human Chorionic Gonadotropin (HCG) Market Share in 2022

Figure 32. North America Human Chorionic Gonadotropin (HCG) Market Share by Country (2018-2029)

Figure 33. U.S. Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 34. Canada Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 35. Germany Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 36. France Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 37. U.K. Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 38. Italy Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 39. Russia Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 40. Nordic Countries Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 41. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share by Region (2018-2029)

Figure 42. China Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 43. Japan Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 44. South Korea Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 46. India Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 47. Australia Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 48. Latin America Human Chorionic Gonadotropin (HCG) Market Share by Country (2018-2029)

Figure 49. Mexico Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 50. Brazil Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 51. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Share by Country (2018-2029)

Figure 52. Turkey Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 54. UAE Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)

Figure 55. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions